Elisa Cuevas

Elisa Cuevas is a scientist with extensive experience in neurodevelopment and a specialization in gene and cell therapy biomedical research. Currently serving as Head of NPD at 4basebio since February 2023, Elisa previously held the position of Lab Director at Axovia Therapeutics, leading a team of ten scientists and focusing on IND-enabling studies. At University College London, significant contributions included establishing CRISPR/Cas9 gene editing techniques and generating preclinical cell therapy research models. Earlier roles involved research at King's College London and Charité, where Elisa developed a conditional knockout mouse model and contributed to multiple publications. Educational qualifications include a PhD in Molecular Biology from Freie Universität Berlin and a BSc/MSc in Molecular Biology from Universidad Autónoma de Madrid.